PACAP 1-38 as an inhaled bronchodilator in guinea pigs in vivo

Peptides

Volumn 19, Issue 1, 1998, Pages 93-98

  Lindén, Anders ^a   Cardell, Lars Olaf ^a   Yoshihara, Shigemi ^a   Stjärne, Pär ^a   Nadel, Jay A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aerosol inhalation; Airway smooth muscle; Blood pressure; Bronchodilator; Carbachol; Heart rate; Histamine; PACAP; Total pulmonary resistance; VIP

Indexed keywords

BRONCHODILATING AGENT; CARBACHOL; HISTAMINE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOSE RESPONSE; GUINEA PIG; HEART RATE; IN VIVO STUDY; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; AIRWAY RESISTANCE; ANIMALS; BLOOD PRESSURE; BRONCHODILATOR AGENTS; CARBACHOL; GUINEA PIGS; HEART RATE; HISTAMINE; LUNG; MALE; NEUROPEPTIDES; PEPTIDE FRAGMENTS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0031914695     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00256-8     Document Type: Article

References (12)

1. Araki N., Takagi K. Relaxant effect of pituitary adenylate cyclase-activating polypeptide on guinea-pig tracheal smooth muscle. Eur. J. Pharmacol. 216:1992;113-117.
2. Arimura A. Pituitary adenylate cyclase activating polypeptide (PACAP) discovery and current status of research . Regul. Pept. 37:1992;287-303.
3. Barnes P., Chung K. F., Page C. F. Inflammatory mediators and asthma. Pharmacol. Rev. 40:1988;49-84.
4. Cardell L-O., Uddman R., Luts A., Sundler F. Pituitary adenylate-cyclase activating peptide (PACAP) in guinea pig lung distribution and dilatory effects . Regul. Pept. 36:1991;379-390.
5. Champion H. C., Santiago J. A., Garrison E. A., Cheng D. Y., Coy D. H., Murphy W. A., Ascuitto R. J., Ross-Ascuitto N. T., McNamara D. B., Kadowitz P. J. Analysis of cardiovascular responses to PACAP-27, PACAP-38 and vasoactive intestinal peptide. Ann. NY Acad. Sci. 805:1996;429-441.
6. Dusser D. J., Umeno E., Graf P. D., Djokic T. D., Borson D. B., Nadel J. A. Airway neutral endopeptidase-like enzymes modulate tachykinin-induced bronchoconstriction in vivo. J. Appl. Physiol. 65:1988;2585-2591.
7. Foda H. D., Sharaf H. H., Absood A., Said S. Pituitary adenylate cyclase-activating peptide (PACAP), a VIP-like peptide, has prolonged airway smooth muscle relaxant activity. Peptides. 16:1995;1057-1061.
8. Ishizuka Y., Kashikoto K., Mochizuki T., Sato K., Oshima K., Yanaihara N. Cardiovascular and respiratory actions of pituitary adenylate cyclase-activating polypeptides. Regul. Pept. 40:1992;29-39.
9. Kanemura T., Tamaoki J., Chiytani A., Takeyama K., Sakai N., Tagaya E., Konno K. Role of Na+-K+-ATPase in airway smooth muscle relaxation by vasoactive intestinal peptide and pituitary adenylate cyclase activating peptide. Res. Commun. Chem. Pathol. Pharmacol. 79:1993;11-22.
10. Lindén A., Yoshihara S., Chan B., Nadel J. A. Inhibition of bronchoconstriction by pituitary adenylate cyclase activating polypeptide (PACAP 1-27) in guinea-pigs in vivo. Br. J. Pharmacol. 115:1995;913-916.
11. Wallin A., Sandström T., Rosenhall L., Melander B. Time course and duration of bronchodilation with formoterol dry powder in patients with stable asthma. Thorax. 48:1993;611-614.
12. Widdicombe, J. G.; Karlsson, J.-A.; Barnes, P. J. Cholinergic mechanisms in bronchial hyperresponsiveness and asthma. In: Kaliner, M. A.; Barnes, P. J.; Persson, C. G. A., Eds. Asthma: its pathology and treatment. New York: Marcel Dekker Inc; 1991;73-101.